Katz Michael David M.D. 4
4 · Hanover Bancorp, Inc. /NY · Filed Aug 15, 2022
Insider Transaction Report
Form 4
Katz Michael David M.D.
Director
Transactions
- Purchase
Common Stock
2022-08-11$19.99/sh+25$500→ 25 total(indirect: See Footnote 1) - Purchase
Common Stock
2022-08-12$20.11/sh+40$804→ 65 total(indirect: See Footnote 1)
Holdings
- 142,793
Common Stock
- 96,760(indirect: See Footnote 2)
Common Stock
Footnotes (2)
- [F1]Held as custodian for Dr. Katz's grandchild
- [F2]Held by a trust to which Dr. Katz is a beneficiary